Cargando…
Sox2 and βIII-Tubulin as Biomarkers of Drug Resistance in Poorly Differentiated Sinonasal Carcinomas
Poorly differentiated sinonasal carcinomas (PDCs) are tumors that have a poor prognosis despite advances in classical treatment. Predictive and prognostic markers and new personalized treatments could improve the oncological outcomes of patients. In this study, we analyzed SOX2 and βIII-tubulin as b...
Autores principales: | López, Luis, Fernández-Vañes, Laura, Cabal, Virginia N., García-Marín, Rocío, Suárez-Fernández, Laura, Codina-Martínez, Helena, Lorenzo-Guerra, Sara L., Vivanco, Blanca, Blanco-Lorenzo, Verónica, Llorente, José L., López, Fernando, Hermsen, Mario A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608336/ https://www.ncbi.nlm.nih.gov/pubmed/37888115 http://dx.doi.org/10.3390/jpm13101504 |
Ejemplares similares
-
Biomarkers for Immunotherapy in Poorly Differentiated Sinonasal Tumors
por: Villanueva-Fernández, Eva, et al.
Publicado: (2022) -
Signaling Pathways mTOR and ERK as Therapeutic Targets in Sinonasal Intestinal-Type Adenocarcinoma
por: Codina-Martínez, Helena, et al.
Publicado: (2023) -
Aberrant Signaling Pathways in Sinonasal Intestinal-Type Adenocarcinoma
por: Riobello, Cristina, et al.
Publicado: (2021) -
CD8(+) Tumour-Infiltrating Lymphocytes and Tumour Microenvironment Immune Types as Biomarkers for Immunotherapy in Sinonasal Intestinal-Type Adenocarcinoma
por: García-Marín, Rocío, et al.
Publicado: (2020) -
Next-generation sequencing for identification of actionable gene mutations in intestinal-type sinonasal adenocarcinoma
por: Sánchez-Fernández, Paula, et al.
Publicado: (2021)